MX9707187A - Derivados de imidazopiridina. - Google Patents

Derivados de imidazopiridina.

Info

Publication number
MX9707187A
MX9707187A MX9707187A MX9707187A MX9707187A MX 9707187 A MX9707187 A MX 9707187A MX 9707187 A MX9707187 A MX 9707187A MX 9707187 A MX9707187 A MX 9707187A MX 9707187 A MX9707187 A MX 9707187A
Authority
MX
Mexico
Prior art keywords
imidazopyridine derivatives
imidazopyridine
derivatives
compounds
formula
Prior art date
Application number
MX9707187A
Other languages
English (en)
Inventor
Andrew Paul Ayscough
Christopher Mark Blackwell
Steven Launchbury
Mark Whittaker
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9516115.4A external-priority patent/GB9516115D0/en
Priority claimed from GBGB9608592.3A external-priority patent/GB9608592D0/en
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Publication of MX9707187A publication Critical patent/MX9707187A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invencion describe compuestos de formula (II), en donde L, A, X, B, R2, R3, W, D, E, R3, R4, R5 son como se definio en la especificacion, los cuales son antagonistas duales del receptor de histamina H1 y de PAF.
MX9707187A 1995-08-05 1996-07-30 Derivados de imidazopiridina. MX9707187A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9516115.4A GB9516115D0 (en) 1995-08-05 1995-08-05 Imidazopyridine derivates
GBGB9608592.3A GB9608592D0 (en) 1996-04-24 1996-04-24 Imidazopyridine derivatives
PCT/GB1996/001849 WO1997006167A1 (en) 1995-08-05 1996-07-30 Imidazopyridine derivatives

Publications (1)

Publication Number Publication Date
MX9707187A true MX9707187A (es) 1997-11-29

Family

ID=27267850

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9707187A MX9707187A (es) 1995-08-05 1996-07-30 Derivados de imidazopiridina.

Country Status (10)

Country Link
US (1) US5866588A (es)
EP (1) EP0842175A1 (es)
JP (1) JPH11510180A (es)
AU (1) AU698487B2 (es)
BR (1) BR9609892A (es)
GB (1) GB2308593B (es)
MX (1) MX9707187A (es)
NZ (1) NZ313726A (es)
SK (1) SK12798A3 (es)
WO (1) WO1997006167A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797820B2 (en) * 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation
JP4591349B2 (ja) 2003-07-14 2010-12-01 宇部興産株式会社 ４−アミノテトラヒドロピラン化合物及びその酸塩の製法、その合成中間体およびその製法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44821B (en) * 1982-02-04 1991-02-28 Wellcome Found Process for obtaiing new pyridyl derivatives
US4621094A (en) * 1983-03-10 1986-11-04 Findlay John W A Anti-histaminic pyridyl compounds
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
GB9107398D0 (en) * 1991-04-09 1991-05-22 British Bio Technology Compounds

Also Published As

Publication number Publication date
GB9708363D0 (en) 1997-06-18
AU6625496A (en) 1997-03-05
US5866588A (en) 1999-02-02
AU698487B2 (en) 1998-10-29
WO1997006167A1 (en) 1997-02-20
JPH11510180A (ja) 1999-09-07
NZ313726A (en) 1998-11-25
SK12798A3 (en) 1998-08-05
GB2308593B (en) 1999-01-27
BR9609892A (pt) 1999-05-25
GB2308593A (en) 1997-07-02
EP0842175A1 (en) 1998-05-20

Similar Documents

Publication Publication Date Title
MX9606203A (es) Derivados heterociclicos sustituidos.
EG25227A (en) Heterocyclic compounds.
ZA9811178B (en) Use of pyrazolo (3,4-b) pyridine as cyclin dependent kinase inhibitors.
ZA965935B (en) Heterocyclic compounds.
MX9705414A (es) Antagonistas de vasopresina triciclicos.
MY118498A (en) Lactam derivatives
DE69203955D1 (de) Benzazepinderivate als Vasopressin-Antagonisten.
ZA964725B (en) Heterocyclic ring-fused pyrimidine derivatives.
AU7131196A (en) Pyrimidine derivatives as 5ht2c-receptor antagonists
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
NZ239921A (en) Substituted xanthine derivatives; medicaments.
HK1043795A1 (en) Substituted bicyclic derivatives useful as anticancer agents.
ZA945193B (en) Novel 1-substituted imidazole compounds as cytokine inhibitors.
HK1018788A1 (en) Antivirally active heterocyclic azahexane derivatives.
EP0758898A4 (en) ACTIVINE ANTAGONISTS FOR USE AS NEW CONTRACEPTIVES
ZA200204510B (en) Imidazopyridine derivatives used as phosphodiesterase VII inhibitors.
AU3461293A (en) Benzodiazepine derivatives, as CCK and gastrin antagonists
CY2380B1 (en) Pde IV inhibiting 2-cyanoiminoimidazole derivatives.
ZA928742B (en) Heterocyclic derivatives.
ZA929934B (en) Heterocyclic derivatives.
BR9612246A (pt) Derivados octaidro-pirrol(1,2-a)pirazinha 2,7-substituidos
ZA978792B (en) N-substituted azaheterocyclic compounds.
EP0662964A1 (en) HETEROCYCLIC AMINES AS CALMODULIN ANTAGONISTE.
EP0681583A1 (en) TRICYCLIC HETEROCYCLIC COMPOUNDS AS 5-HT4 RECEPTOR ANTAGONISTS.
MX9707187A (es) Derivados de imidazopiridina.